To determine the existence of anti-MUC16 CT mAb reactive proteolytic cleavage products originating from native MUC16 backbone, lysates of ovarian cancer cell lines expressing high levels of endogenous MUC16 were analyzed by western blotting. The gene discussed is MUC16; the disease is ovarian carcinoma.